Collagen peptides
Also: Hydrolyzed collagen · Collagen hydrolysate
- Status
- Approved
- Evidence
- Moderate
- Field
Cosmetic
1
What it is
A food ingredient with a better evidence trail than most 'skin peptides' sold as injectables. Effects are modest. It is not equivalent to a prescription regenerative drug.
2
How it works
Oral hydrolyzed collagen supplies small peptides and amino acids (notably glycine, proline, hydroxyproline). Proposed effects include providing substrate and bioactive di/tripeptides that may influence dermal fibroblasts. This is nutrition-plus, not receptor pharmacology like GLP-1.
3
The evidence
Multiple RCTs, including dermatology-focused trials, report small improvements in skin elasticity and wrinkle measures versus placebo. Joint-pain trials are mixed but not empty. Heterogeneity of source (bovine, marine) and dose is high.
4
Sourcing
Sold as a dietary supplement / food in the US. Not a drug, and not evaluated by FDA for disease claims.
A food ingredient / dietary supplement from grocery and supplement retailers. Look for food-grade hydrolyzed collagen with a manufacturer and lot. This is not a prescription, and it is not an injectable regenerative drug.
Same four pathways as the Sourcing guide.
5
Will insurance pay?
Not a drug benefit. Some FSAs/HSAs reimburse supplements with a letter of medical necessity; most do not. Out-of-pocket is the norm.
6
Grey market
Low concern relative to injectables. The failure mode is contaminant quality and disease-claim marketing, not a Telegram vial. Avoid 'research collagen' ampoules for injection.
Strand does not list vendors. See the grey market.
7
Risks
Generally recognized as a food protein. Allergies (fish, bovine) matter. Contaminant quality varies by manufacturer — pick food-grade, not research vials.
- Allergies (fish, bovine) matter.
- Effects are modest; disease claims are not FDA-evaluated.
- Do not inject a food powder.
8
Papers
Dermatology RCTs · 2014 · Skin Pharmacol Physiol
Proksch et al. Oral collagen peptide supplementation and skin elasticity. PMID 23949208.
Joint-pain reviews
Mixed, modest effects across osteoarthritis trials — heterogeneity of source and dose is high.
Related
- GHK-Cu — Research